Incyte Corporation (INCY)
NASDAQ
5 marketed ·
Quick facts
Marketed products
- Pemazyre · Oncology · revenue 200
Pemazyre blocks the activity of the FGFR1 protein, which is involved in the growth and spread of cancer cells. - Niktimvo · Immunology
Niktimvo blocks the Colony Stimulating Factor-1 Receptor to reduce inflammation and prevent damage to healthy tissues. - R-CHOP · Other
- Zynyz · Oncology
Zynyz works by blocking the PD-1 receptor on immune cells, allowing them to recognize and attack cancer cells. - ZYNYZ · Oncology